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A 41-year-old woman presented to the hemodialysis (HD) unit
with cyanosis of the lips that she noted to have progressively
worsened over a 3-week period (Figure 1). There was no
associated dyspnea. She had a history of type 1 diabetes
mellitus, resulting in end-stage renal disease. Peritoneal dialysis
(PD) was initiated 8 months before presentation, and she was
subsequently switched to HD because of poor PD catheter
function 3 months before presentation. She was also known to
have hypertension, hyperlipidemia, asthma, epilepsy, celiac
disease, dermatitis herpetiformis, and a Charcot foot. Medica-
tions included insulin, aspirin, simvastatin, diltiazem, valsartan,
budesonide/formoterol, dapsone, gabapentin, levetiracetam,
primidone, calcium carbonate, sevelamer hydrochloride,
calcitriol, and epoetin alfa.
On examination, she was in no distress. Blood pressure
before dialysis was 162/90, with a pulse of 84 beats per
minute, a respiratory rate of 14 breaths per minute, and an
oxygen saturation that ranged from 89 to 92%. She was
afebrile. Prominent cyanosis of her lips was noted (Figure 1).
Auscultation of her lungs was unremarkable, and there was
no clubbing. Cardiac auscultation revealed normal heart
sounds with the exception of an S4. She had mild ankle
edema bilaterally.
Arterial blood gas showed a PaO2 of 81mmHg, with an
oxygen saturation of 94%. Hemoglobin was 95 g/l. Chest
radiograph was normal. Her most recent echocardiogram
from 10 months before presentation was normal with the
exception of concentric left ventricular remodeling.
What is the cause of her cyanosis?
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Figure 1 |Cyanosis of the lips.
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The Diagnosis | Methemoglobinemia due to dapsone
This patient had pronounced cyanosis. Her lack of symp-
toms, along with the normal cardiorespiratory examination
and chest radiograph led us to pursue other potential
diagnoses. Because of the chronic dapsone use and the dark
color of her venous blood, the possibility of methemoglobi-
nemia was raised. The arterial blood sample was sent for co-
oximetry, confirming a methemoglobin level of 21.2%
(normal o1%).
Methemoglobin is an alternate state of hemoglobin in
which the ferrous iron of heme is oxidized to the ferric state.
Because the ferric state of methemoglobin cannot bind
oxygen, patients with increased levels of methemoglobin can
become symptomatic as a result of impaired tissue oxygen
delivery. Symptoms may include headache, dyspnea, fatigue,
dizziness and mental status changes. The cyanosis that is seen
with increasing methemoglobin levels is due to the different
absorbance spectrum of methemoglobin compared with
oxyhemoglobin.
There are several causes of methemoglobinemia, including
congenital disorders and certain medications, with dapsone
being the most common.1,2 Additional causes in hemodia-
lysis patients have included chloramines, hydrogen peroxide
and nitrates in the water supply3–6 (Table 1). Interestingly,
our patient had been on the same dose of dapsone (200mg
daily) for management of dermatitis herpetiformis for
approximately 20 years. However, as dapsone is renally
excreted, it is possible that loss of residual renal function led
to its accumulation. On further questioning, the patient
described a major decline in urine volume since initiating
HD 3 months before. Although there is some dapsone
removal through HD,7,8 the dialytic clearance is limited by
protein binding, such that it was likely insufficient to
compensate for the declining renal elimination.
Management generally consists of discontinuing the
offending agent in asymptomatic patients with methemoglobin
levels of o20%. For symptomatic patients or those with
levels 420%, treatment with methylene blue is recom-
mended as a reducing agent to convert the iron of heme back
into its ferrous state. Our patient was advised to discontinue
dapsone, and was treated with methylene blue 1mg/kg i.v.
after completion of her dialysis session. Repeat methemoglo-
bin level 10min later was 2.7%, and the levels at subsequent
HD sessions were 6.7 and 3.5%.
In summary, although central cyanosis is most often due
to lung or cardiac disease, alternate diagnostic possibilities
should be entertained in patients with cyanosis that does not
fit the clinical picture. Dapsone is a well-known cause of
methemoglobinemia, and its renal clearance may increase the
risk of this rare complication among patients with renal
insufficiency if dose adjustments are not made.
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Table 1 | Causes of methemoglobinemia
Most commonly used agents known to cause acquired
methemoglobinemia in the general population Reported causes of methemoglobinemia in dialysis patients
Dapsone Dapsone
Local anesthetic agents Chloramines
Nitrites/nitrates Hydrogen peroxide water disinfection
Sulfonamides Well-water nitrates
Chloroquine
Primaquine
Metoclopramide
Rasburicase
p-Aminosalicylic acid
Zopiclone
Methylene blue (in high doses or in individuals with G6PD deficiency)
328 Kidney International (2010) 78, 327–328
make your d iagnos i s SJ Nessim and ML Lipman: Cyanosis in a hemodialysis patient
